IGF1-LR3

Product Overview

IGF-1 LR3 is a long-acting insulin-like growth factor analog, frequently evaluated in biochemical research and cellular modeling for its relevance in growth factor signaling, receptor interactions, and tissue development pathways. This 1 mg lyophilized peptide enables controlled laboratory assessments of purity stability and mechanistic behavior.

Peptide Overview

From 2010 to 2025, IGF-1 LR3 has been extensively examined for its extended half-life properties, enhanced receptor binding potential, and biochemical significance in IGF/insulin pathway modeling. Its stability and well-defined analytical profile support reproducible in vitro research conditions.

Historical and Scientific Context

Research on IGF-related pathways has significantly expanded since 2014, as laboratories sought to better understand cellular growth signaling, tissue development mechanisms, and metabolic regulation models. IGF-1 LR3 remains a central compound for studying long-acting analogs with modified receptor affinity and enhanced biochemical signaling.

Research Focus on Mechanisms

• Modeling of growth factor signaling pathways

• Receptor interaction and in vitro response evaluation

• Comparative structural analysis of IGF-class analogs

• Studies on cellular development and metabolic regulation

• Biochemical modeling in controlled laboratory environments